Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Category
US Equities - Industry Sector
Sponsor
Invesco
Fund Family
Index
Dynamic Biotechnology & Genome Intellide...
Index Weighting
Active/Passive
Expense
0.59%
Inverse/Leveraged
IPO
Jun 23, 2005
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-3.40%
SMA50
-0.67%
SMA200
9.80%
Return% 1Y
26.80%
Return% 3Y
21.86%
Return% 5Y
6.16%
Return% 10Y
Return% SI
Flows% 1M
2.31%
Flows% 3M
8.46%
Flows% YTD
38.04%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
31
AUM
434.25M
NAV/sh
52W High
104.69 -7.50%
52W Low
75.50 28.26%
Volatility
1.56% 1.76%
ATR (14)
1.90
RSI (14)
43.61
Beta
0.71
Rel Volume
0.64
Avg Volume
18.12K
Volume
5,173
Perf Week
-3.97%
Perf Month
0.79%
Perf Quarter
1.64%
Perf Half Y
20.46%
Perf YTD
17.88%
Perf Year
24.52%
Perf 3Y
74.93%
Perf 5Y
34.31%
Perf 10Y
124.53%
Prev Close
97.88
Price
96.84
Change %
-1.06%
Invesco Dynamic Biotechnology & Genome ETF seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.